CGE21-031: Genomic Biomarker Testing, Treatments, and Survival Outcomes Among Patients With Advanced or Metastatic NSCLC in the US: A Retrospective Cohort Study

Authors:
Yajun Zhu Eli Lilly and Company, Indianapolis, IN

Search for other papers by Yajun Zhu in
Current site
Google Scholar
PubMed Close
 MS, MBA
,
Yimei Han Eli Lilly and Company, Indianapolis, IN

Search for other papers by Yimei Han in
Current site
Google Scholar
PubMed Close
 MS
,
Naleen Raj Bhandari Eli Lilly and Company, Indianapolis, IN

Search for other papers by Naleen Raj Bhandari in
Current site
Google Scholar
PubMed Close
 Phd
, and
Lisa Hess Eli Lilly and Company, Indianapolis, IN

Search for other papers by Lisa Hess in
Current site
Google Scholar
PubMed Close
 PhD
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7708
Restricted access

Corresponding Author: Yajun Zhu, MS, MBA
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1774 533 141
PDF Downloads 983 0 0
EPUB Downloads 0 0 0